출혈 방지 겔 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2031년)

Persistence Market Research has recently published an extensive report on the global Anti-Bleeding Gel Market. This report provides a comprehensive analysis of key market dynamics, including growth drivers, trends, opportunities, and challenges, offering in-depth insights into the market structure.

Key Insights:

• Anti-Bleeding Gel Market Size (2024E): US$6.1 Bn
• Projected Market Value (2031F): US$9.2 Bn
• Global Market Growth Rate (CAGR 2024 to 2031):6.1%

Anti-Bleeding Gel Market - Report Scope:

The Anti-Bleeding Gel Market encompasses a variety of gel-based products that help control bleeding and facilitate clotting. These products are increasingly used in medical, surgical, and emergency situations, as well as in over-the-counter wound care applications. Anti-bleeding gels are designed to stop bleeding quickly and effectively, making them essential in situations ranging from minor cuts to severe traumatic injuries. The market includes gels used in hospitals, clinics, ambulances, and home care settings, and features a range of products with different formulations for various bleeding conditions. The growing focus on improving emergency medical care and first aid awareness drives market demand.

Market Growth Drivers:

The Anti-Bleeding Gel Market is experiencing significant growth, driven by several key factors. The increasing number of surgical procedures worldwide, along with the rising incidence of trauma and accidents, is propelling the demand for effective bleeding control solutions. The gels offer a quick and effective way to manage bleeding, making them highly sought-after in emergency medicine and trauma care. Additionally, advancements in product formulations, such as the inclusion of bioactive ingredients that enhance clotting efficiency, are contributing to the market's expansion. The growing awareness of first aid, especially in remote and developing regions, is further boosting the market.

Market Restraints:

Despite its growth potential, the Anti-Bleeding Gel Market faces certain challenges. High costs associated with advanced anti-bleeding gel formulations can limit accessibility, particularly in low-income regions. Moreover, there are concerns about potential side effects, such as allergic reactions to certain ingredients, which may hinder widespread adoption. The stringent regulatory requirements for medical products in various countries also pose challenges to market players, particularly for new entrants. Additionally, the availability of alternative bleeding control products, such as traditional bandages and hemostatic powders, may affect the market growth.

Market Opportunities:

The Anti-Bleeding Gel Market presents significant opportunities due to the rising demand for advanced wound care products and the ongoing development of bioactive and biodegradable gels. There is an increasing interest in gels that incorporate natural hemostatic agents or synthetic polymers that can dissolve after the bleeding is controlled, thereby reducing the need for removal. Furthermore, the expansion of telemedicine and online healthcare services is creating opportunities for direct-to-consumer sales of anti-bleeding products. Increasing investments in healthcare infrastructure, especially in emerging economies, are likely to further drive market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Anti-Bleeding Gel Market globally?
• Which types and formulations of anti-bleeding gels are leading the adoption in different regions?
• How are technological advancements impacting the competitive landscape of the Anti-Bleeding Gel Market?
• Who are the key players in the Anti-Bleeding Gel Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Anti-Bleeding Gel Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Anti-Bleeding Gel Market, including Baxter International Inc., HemCon Medical Technologies Inc., and Z-Medica LLC, are focusing on product innovation, enhanced bioavailability of active ingredients, and strategic partnerships to gain a competitive edge. These companies invest significantly in R&D to develop advanced formulations that improve the efficiency of bleeding control while minimizing side effects. Partnerships with healthcare providers and emergency services facilitate product adoption and increase brand visibility. Emphasis on consumer education and the development of user-friendly packaging also play a role in enhancing market growth and brand loyalty.

Key Companies Profiled:

• Cresilon Inc.
• Baxter Healthcare Corporation
• Z-Medica
• Steve Kelly
• Ethicon
• Pfizer Inc.
• CR Bard
• Hemcon Medical Technologies Inc
• Abbott Laboratories
• Johnson & Johnson

Anti-Bleeding Gel Market Industry Segmentation:

By Product

• Veterinary Use
• Human Use

By Indication

• Biopsies of Soft Tissue
• Trauma
• Enucleations
• Orthopaedic Surgeries
• Others

By Distribution Channel

• Retail Pharmacy
• Online Pharmacy
• Veterinary Pharmacy
• Others

By Region

• North America
• Europe
• Asia Pacific
• The Middle East and Africa
• Latin America

Table of Contents

1. Executive Summary

• 1.1. Global Anti-bleeding Gel Market Snapshot, 2024-2033
• 1.2. Market Opportunity Assessment, 2024-2033, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
  • 2.3.3. Global Healthcare Spending Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Product Adoption Analysis
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Global Anti-bleeding Gel Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2033
• 4.3. Global Anti-bleeding Gel Market Outlook: Product Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2023
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2033
    • 4.3.3.1. Veterinary Use
    • 4.3.3.2. Human Use
• 4.4. Market Attractiveness Analysis: Product Type
• 4.5. Global Anti-bleeding Gel Market Outlook: Indication
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
    • 4.5.3.1. Biopsies of Soft Tissue
    • 4.5.3.2. Trauma
    • 4.5.3.3. Enucleations
    • 4.5.3.4. Orthopedic Surgeries
    • 4.5.3.5. Others
• 4.6. Market Attractiveness Analysis: Indication
• 4.7. Global Anti-bleeding Gel Market Outlook: Distribution Channel
  • 4.7.1. Introduction / Key Findings
  • 4.7.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
  • 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2033
    • 4.7.3.1. Retail Pharmacy
    • 4.7.3.2. Online Pharmacy
    • 4.7.3.3. Veterinary Pharmacy
    • 4.7.3.4. Others
• 4.8. Market Attractiveness Analysis: Distribution Channel

5. Global Anti-bleeding Gel Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2033
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Anti-bleeding Gel Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 6.2.1. By Country
  • 6.2.2. By Product Type
  • 6.2.3. By Indication
  • 6.2.4. By Distribution Channel
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2033
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2033
  • 6.4.1. Veterinary Use
  • 6.4.2. Human Use
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
  • 6.5.1. Biopsies of Soft Tissue
  • 6.5.2. Trauma
  • 6.5.3. Enucleations
  • 6.5.4. Orthopedic Surgeries
  • 6.5.5. Others
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2033
  • 6.6.1. Retail Pharmacy
  • 6.6.2. Online Pharmacy
  • 6.6.3. Veterinary Pharmacy
  • 6.6.4. Others
• 6.7. Market Attractiveness Analysis

7. Europe Anti-bleeding Gel Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 7.2.1. By Country
  • 7.2.2. By Product Type
  • 7.2.3. By Indication
  • 7.2.4. By Distribution Channel
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2033
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkiye
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2033
  • 7.4.1. Veterinary Use
  • 7.4.2. Human Use
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
  • 7.5.1. Biopsies of Soft Tissue
  • 7.5.2. Trauma
  • 7.5.3. Enucleations
  • 7.5.4. Orthopedic Surgeries
  • 7.5.5. Others
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2033
  • 7.6.1. Retail Pharmacy
  • 7.6.2. Online Pharmacy
  • 7.6.3. Veterinary Pharmacy
  • 7.6.4. Others
• 7.7. Market Attractiveness Analysis

8. East Asia Anti-bleeding Gel Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 8.2.1. By Country
  • 8.2.2. By Product Type
  • 8.2.3. By Indication
  • 8.2.4. By Distribution Channel
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2033
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2033
  • 8.4.1. Veterinary Use
  • 8.4.2. Human Use
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
  • 8.5.1. Biopsies of Soft Tissue
  • 8.5.2. Trauma
  • 8.5.3. Enucleations
  • 8.5.4. Orthopedic Surgeries
  • 8.5.5. Others
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2033
  • 8.6.1. Retail Pharmacy
  • 8.6.2. Online Pharmacy
  • 8.6.3. Veterinary Pharmacy
  • 8.6.4. Others
• 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Anti-bleeding Gel Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 9.2.1. By Country
  • 9.2.2. By Product Type
  • 9.2.3. By Indication
  • 9.2.4. By Distribution Channel
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2033
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2033
  • 9.4.1. Veterinary Use
  • 9.4.2. Human Use
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
  • 9.5.1. Biopsies of Soft Tissue
  • 9.5.2. Trauma
  • 9.5.3. Enucleations
  • 9.5.4. Orthopedic Surgeries
  • 9.5.5. Others
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2033
  • 9.6.1. Retail Pharmacy
  • 9.6.2. Online Pharmacy
  • 9.6.3. Veterinary Pharmacy
  • 9.6.4. Others
• 9.7. Market Attractiveness Analysis

10. Latin America Anti-bleeding Gel Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 10.2.1. By Country
  • 10.2.2. By Product Type
  • 10.2.3. By Indication
  • 10.2.4. By Distribution Channel
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2033
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2033
  • 10.4.1. Veterinary Use
  • 10.4.2. Human Use
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
  • 10.5.1. Biopsies of Soft Tissue
  • 10.5.2. Trauma
  • 10.5.3. Enucleations
  • 10.5.4. Orthopedic Surgeries
  • 10.5.5. Others
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2033
  • 10.6.1. Retail Pharmacy
  • 10.6.2. Online Pharmacy
  • 10.6.3. Veterinary Pharmacy
  • 10.6.4. Others
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Anti-bleeding Gel Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  • 11.2.1. By Country
  • 11.2.2. By Product Type
  • 11.2.3. By Indication
  • 11.2.4. By Distribution Channel
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2033
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2033
  • 11.4.1. Veterinary Use
  • 11.4.2. Human Use
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
  • 11.5.1. Biopsies of Soft Tissue
  • 11.5.2. Trauma
  • 11.5.3. Enucleations
  • 11.5.4. Orthopedic Surgeries
  • 11.5.5. Others
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2033
  • 11.6.1. Retail Pharmacy
  • 11.6.2. Online Pharmacy
  • 11.6.3. Veterinary Pharmacy
  • 11.6.4. Others
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2024
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Cresilon Inc.
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Baxter Healthcare Corporation
    • 12.3.2.1. Overview
    • 12.3.2.2. Segments and Products
    • 12.3.2.3. Key Financials
    • 12.3.2.4. Market Developments
    • 12.3.2.5. Market Strategy
  • 12.3.3. Z-Medica
    • 12.3.3.1. Overview
    • 12.3.3.2. Segments and Products
    • 12.3.3.3. Key Financials
    • 12.3.3.4. Market Developments
    • 12.3.3.5. Market Strategy
  • 12.3.4. Steve Kelly
    • 12.3.4.1. Overview
    • 12.3.4.2. Segments and Products
    • 12.3.4.3. Key Financials
    • 12.3.4.4. Market Developments
    • 12.3.4.5. Market Strategy
  • 12.3.5. Ethicon
    • 12.3.5.1. Overview
    • 12.3.5.2. Segments and Products
    • 12.3.5.3. Key Financials
    • 12.3.5.4. Market Developments
    • 12.3.5.5. Market Strategy
  • 12.3.6. Pfizer Inc.
    • 12.3.6.1. Overview
    • 12.3.6.2. Segments and Products
    • 12.3.6.3. Key Financials
    • 12.3.6.4. Market Developments
    • 12.3.6.5. Market Strategy
  • 12.3.7. CR Bard
    • 12.3.7.1. Overview
    • 12.3.7.2. Segments and Products
    • 12.3.7.3. Key Financials
    • 12.3.7.4. Market Developments
    • 12.3.7.5. Market Strategy
  • 12.3.8. Hemcon Medical Technologies Inc
    • 12.3.8.1. Overview
    • 12.3.8.2. Segments and Products
    • 12.3.8.3. Key Financials
    • 12.3.8.4. Market Developments
    • 12.3.8.5. Market Strategy
  • 12.3.9. Abbott Laboratories
    • 12.3.9.1. Overview
    • 12.3.9.2. Segments and Products
    • 12.3.9.3. Key Financials
    • 12.3.9.4. Market Developments
    • 12.3.9.5. Market Strategy
  • 12.3.10. Johnson & Johnson
    • 12.3.10.1. Overview
    • 12.3.10.2. Segments and Products
    • 12.3.10.3. Key Financials
    • 12.3.10.4. Market Developments
    • 12.3.10.5. Market Strategy

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations